Hesperadin Suppresses Pancreatic Cancer through ATF4/GADD45A Axis at Nanomolar Concentrations

Scientists identified Hesperadin as a potent anti-cancer compound against pancreatic cancer, from a high-throughput screening of a commercial chemical library associated with cell death.